The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass
Information source: Federal University of Juiz de Fora
ClinicalTrials.gov processed this data on August 20, 2015
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Glycemia During Coronary Artery Bypass Graft; Sedation During Pre-anesthetic Medication
Intervention: Clonidine (Drug); Ringer lactato (Drug)
Phase: Phase 4
Status: Completed
Sponsored by: Federal University of Juiz de Fora
Summary
The purpose of this study is the randomized blind research of the assessment of the
different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary
by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response
during cardiac surgery, the investigators would like to know if the glycemia levels in
clondine group will be lower than placebo group.
Clinical Details
Official title: The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass.
Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Investigator), Primary Purpose: Treatment
Primary outcome: sedation
Secondary outcome: Glycemia
Eligibility
Minimum age: 45 Years.
Maximum age: 80 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- elective CABG EF > 40% Sinus ritmy
Exclusion Criteria:
- precordialgia emergency surgery combinated surgery not agreement
Locations and Contacts
National institut of Cardiology, Rio de Janeiro, RJ 3600/100, Brazil
Additional Information
Starting date: January 2011
Last updated: June 13, 2012
|
